Pletal-Cilostazol

This page contains recent news articles, when available, and an overview of Pletal-Cilostazol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

UCB acquistion of Schwarz Pharma moves ever closer  -  Dec 12, 2006
Pharma Times (subscription),Meantime, Schwarz has announced an agreement with Otsuka Pharmaceutical of Japan to jointly market the latter's Pletal (cilostazol) for stage II peripheral

SCHWARZ PHARMA Announces Agreement With OTSUKA For Jointly ...  -  Dec 14, 2006
Medical News Today (press release),Pletal (cilostazol, developed by Otsuka) is an oral treatment drug for stage II peripheral arterial occlusive disease (intermittent claudication) that has

Business News  -  Dec 19, 2006
American Digital Networks (press release),Pletal (cilostazol) - launched January 1999 for the intermittent claudication associated with peripheral arterial disease.

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.